MCG Pharma

 

The first medicinal cannabis company lists in London

In February 2021 Tavistock helped make history as PR advisor to MGC Pharmaceuticals, the first medicinal cannabis company to IPO on the London Stock Exchange, which raised £6.5m in the process. This listing is a significant moment in the UK medicinal cannabis industry and the fast developing global sector, generating wide media interest in the UK and further afield. The listing comes after a change in the FCA rules in September 2020 which launched a rush of companies hoping to blaze a trail onto the market.

MGC Pharma is a European based bio-pharma company developing and supplying affordable standardised phyto-medicines to patients globally. It’s research and treatments are focused on using phytomedicines in three core areas: Neurology, Oncology, and Autoimmune diseases – including ArtemiC™ for treatment of Covid-19 infected patients.